open access

Vol 89, No 4 (2021)
Review paper
Published online: 2021-07-09
Submitted: 2021-03-07
Accepted: 2021-06-09
Get Citation

Potential benefits and hazards associated with the use of e-cigarettes — a guide for practitioners and current status in Poland

Jakub Kruszewski12, Daniel Worobiej13, Weronika Kolasińska12, Rafał Andrzej Sokołowski3, Michał Rząd32
DOI: 10.5603/ARM.a2021.0058
·
Pubmed: 34269407
·
Adv Respir Med 2021;89(4):392-402.
Affiliations
  1. Faculty of Medicine, Medical Univeristy of Warsaw, Warsaw, Poland
  2. Department of Internal Diseases, Pneumonology, Allergology and Clinical Immunology, Military Health Institute, Warsaw, Poland
  3. Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland

open access

Vol 89, No 4 (2021)
REVIEWS
Published online: 2021-07-09
Submitted: 2021-03-07
Accepted: 2021-06-09

Abstract

The use of electronic cigarettes has dynamically increased over the last few years. Meanwhile, the knowledge regarding their safety has been rapidly changing, which could be a challenge for a medical practitioner. The purpose of this review is to summarize the latest reports and to verify statements on e-cigarettes’ influence on health, including in the context of the ongoing SARS-CoV-2 pandemic. Awareness of the benefits of e-cigarettes can provide vital support for doctors caring for patients who smoke tra-ditional cigarettes. Nevertheless, attention should be paid to the dangers of the medically unjustified use of electronic cigarettes. Despite the idea of releasing e-cigarettes into the market as a harmless alternative to traditional cigarettes, this product also has a negative impact on health. Replacing traditional cigarettes with e-cigarettes provides well-documented benefits to patients with certain indications such as hypertension and asthma, as well as to smokers who intend to minimize the negative effects of passive smoking on their environment. Moreover, it could be valuable for patients who are willing to permanently overcome a nicotine addiction, especially when previous attempts to quit smoking with nicotine replacement therapy (NRT) monotherapy were unsuccessful. Electronic cigarettes are a rapidly developing technology and an innovative form of a well-known addiction, so it is essential for practitioners to stay informed.

Abstract

The use of electronic cigarettes has dynamically increased over the last few years. Meanwhile, the knowledge regarding their safety has been rapidly changing, which could be a challenge for a medical practitioner. The purpose of this review is to summarize the latest reports and to verify statements on e-cigarettes’ influence on health, including in the context of the ongoing SARS-CoV-2 pandemic. Awareness of the benefits of e-cigarettes can provide vital support for doctors caring for patients who smoke tra-ditional cigarettes. Nevertheless, attention should be paid to the dangers of the medically unjustified use of electronic cigarettes. Despite the idea of releasing e-cigarettes into the market as a harmless alternative to traditional cigarettes, this product also has a negative impact on health. Replacing traditional cigarettes with e-cigarettes provides well-documented benefits to patients with certain indications such as hypertension and asthma, as well as to smokers who intend to minimize the negative effects of passive smoking on their environment. Moreover, it could be valuable for patients who are willing to permanently overcome a nicotine addiction, especially when previous attempts to quit smoking with nicotine replacement therapy (NRT) monotherapy were unsuccessful. Electronic cigarettes are a rapidly developing technology and an innovative form of a well-known addiction, so it is essential for practitioners to stay informed.

Get Citation

Keywords

electronic cigarettes, smoking, nicotine addiction, SARS-CoV-2

About this article
Title

Potential benefits and hazards associated with the use of e-cigarettes — a guide for practitioners and current status in Poland

Journal

Advances in Respiratory Medicine

Issue

Vol 89, No 4 (2021)

Article type

Review paper

Pages

392-402

Published online

2021-07-09

DOI

10.5603/ARM.a2021.0058

Pubmed

34269407

Bibliographic record

Adv Respir Med 2021;89(4):392-402.

Keywords

electronic cigarettes
smoking
nicotine addiction
SARS-CoV-2

Authors

Jakub Kruszewski
Daniel Worobiej
Weronika Kolasińska
Rafał Andrzej Sokołowski
Michał Rząd

References (80)
  1. Pinkas J, Kaleta D, Zgliczyński WS, et al. The prevalence of tobacco and e-cigarette use in Poland: a 2019 nationwide cross-sectional survey. Int J Environ Res Public Health. 2019; 16(23).
  2. Laverty AA, Filippidis FT, Vardavas CI. Patterns, trends and determinants of e-cigarette use in 28 European Union Member States 2014-2017. Prev Med. 2018; 116: 13–18.
  3. Główny Inspektorat Sanitarny, Portal Gov.pl. Postawy Polaków wobec palenia tytoniu – Raport 2019 r. Główny Inspektorat Sanitarny. Available online: www.gov.pl/web/gis/postawy-polakow-wobec-palenia-tytoniu--raport-2017. [Last accessed at: 10.02.2021].
  4. Yong HH, Borland R, Cummings KM, et al. Reasons for regular vaping and for its discontinuation among smokers and recent ex-smokers: findings from the 2016 ITC Four Country Smoking and Vaping Survey. Addiction. 2019; 114 Suppl 1: 35–48.
  5. Smith DM, Gawron M, Balwicki L, et al. Exclusive versus dual use of tobacco and electronic cigarettes among adolescents in Poland, 2010-2016. Addict Behav. 2019; 90: 341–348.
  6. Słownik języka polskiego PWN. E-papieros — definicja, synonimy, przykłady użycia. Available online: https://sjp.pwn.pl/slowniki/e-papieros.html. [Last accessed at: 10.02.2021].
  7. Polish Journal of Laws from 1996, No. 10, item 55.
  8. Shields PG, Berman M, Brasky TM, et al. A review of pulmonary toxicity of electronic cigarettes in the context of smoking: a focus on inflammation. Cancer Epidemiol Biomarkers Prev. 2017; 26(8): 1175–1191.
  9. Crotty Alexander LE, Shin S, Hwang JH. Inflammatory diseases of the lung induced by conventional cigarette smoke: a review. Chest. 2015; 148(5): 1307–1322.
  10. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420(6917): 860–867.
  11. De Smet EG, Mestdagh P, Vandesompele Jo, et al. Non-coding RNAs in the pathogenesis of COPD. Thorax. 2015; 70(8): 782–791.
  12. Jayes L, Haslam P, Gratziou C, et al. SmokeHaz. Chest. 2016; 150(1): 164–179.
  13. Burke H, Leonardi-Bee Jo, Hashim A, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics. 2012; 129(4): 735–744.
  14. Merianos AL, Dixon CA, Mahabee-Gittens EM. Secondhand smoke exposure, illness severity, and resource utilization in pediatric emergency department patients with respiratory illnesses. J Asthma. 2017; 54(8): 798–806.
  15. den Dekker HT, Voort AMv, de Jongste JC, et al. Tobacco smoke exposure, airway resistance, and asthma in school-age children: the generation R study. Chest. 2015; 148(3): 607–617.
  16. Kaisar MA, Prasad S, Liles T, et al. A decade of e-cigarettes: Limited research & unresolved safety concerns. Toxicology. 2016; 365: 67–75.
  17. Vardavas C, Anagnostopoulos N, Kougias M, et al. Short-term pulmonary effects of using an electronic cigarette. Chest. 2012; 141(6): 1400–1406.
  18. Allen J, Flanigan S, LeBlanc M, et al. Flavoring chemicals in e-cigarettes: diacetyl, 2,3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored e-cigarettes. Environmental Health Perspectives. 2016; 124(6): 733–739.
  19. Shivalingappa PC, Hole R, Westphal CV, et al. Airway exposure to e-cigarette vapors impairs autophagy and induces aggresome formation. Antioxid Redox Signal. 2016; 24(4): 186–204.
  20. Osei AD, Mirbolouk M, Orimoloye OA, et al. The association between e-cigarette use and asthma among never combustible cigarette smokers: behavioral risk factor surveillance system (BRFSS) 2016 & 2017. BMC Pulm Med. 2019; 19(1): 180.
  21. Polosa R, Morjaria JB, Caponnetto P, et al. Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes. Discov Med. 2016; 21(114): 99–108.
  22. Mishra S. Are e-cigarettes beneficial for public health: Hume's guillotine. The debate continues? Indian Heart J. 2017; 69(6): 810–813.
  23. Layden JE, Ghinai I, Pray I, et al. Pulmonary illness related to e-cigarette use in illinois and wisconsin — final report. N Engl J Med. 2020; 382(10): 903–916.
  24. Henry TS, Kanne JP, Kligerman SJ. Imaging of vaping-associated lung disease. N Engl J Med. 2019; 381(15): 1486–1487.
  25. Blount BC, Karwowski MP, Shields PG, et al. Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI. N Engl J Med. 2020; 382(8): 697–705.
  26. Health CO on S and. Smoking and Tobacco Use; Electronic Cigarettes. Centers for Disease Control and Prevention. 2020. Available online: www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html. [Last accessed at 10.02.2020].
  27. Sobczak A. Zmierzch elektronicznych papierosów? Available online: www.mp.pl/social/article/224877. [Last accessed at: 10.02.2020].
  28. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014. Available online: www.ncbi.nlm.nih.gov/books/NBK179276/. [Last accessed at: 14.02.2021]. .
  29. Laustiola KE, Lassila R, Nurmi AK. Enhanced activation of the renin-angiotensin-aldosterone system in chronic cigarette smokers: a study of monozygotic twin pairs discordant for smoking. Clin Pharmacol Ther. 1988; 44(4): 426–430.
  30. Nikotyna — Medycyna Praktyczna: opis, ceny, refundacja. Available online: www.mp.pl/pacjent/leki/subst.html?id=604. [Last accessed at: 10.02.2021].
  31. Meurrens K, Ruf S, Ross G, et al. Smoking accelerates the progression of hypertension-induced myocardial hypertrophy to heart failure in spontaneously hypertensive rats. Cardiovasc Res. 2007; 76(2): 311–322.
  32. Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis. 2003; 46(1): 91–111.
  33. Kianoush S, Yakoob MY, Al-Rifai M, et al. Associations of cigarette smoking with subclinical inflammation and atherosclerosis: elsa-brasil (the brazilian longitudinal study of adult health). J Am Heart Assoc. 2017; 6(6).
  34. Pappas RS, Gray N, Gonzalez-Jimenez N, et al. Toxic metal concentrations in mainstream smoke from cigarettes available in the USA. J Anal Toxicol. 2014; 38(4): 204–211.
  35. Bernhard D, Csordas A, Henderson B, et al. Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules. FASEB J. 2005; 19(9): 1096–1107.
  36. Abu-Hayyeh S, Sian M, Jones KG, et al. Cadmium accumulation in aortas of smokers. Arterioscler Thromb Vasc Biol. 2001; 21(5): 863–867.
  37. Farsalinos KE, Voudris V, Poulas K. Are metals emitted from electronic cigarettes a reason for health concern? A risk-assessment analysis of currently available literature. Int J Environ Res Public Health. 2015; 12(5): 5215–5232.
  38. Goniewicz ML, Gupta R, Lee YH, et al. Nicotine levels in electronic cigarette refill solutions: A comparative analysis of products from the U.S., Korea, and Poland. Int J Drug Policy. 2015; 26(6): 583–588.
  39. Yan XS, D'Ruiz C. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul Toxicol Pharmacol. 2015; 71(1): 24–34.
  40. Polosa R, Morjaria JB, Caponnetto P, et al. Blood pressure control in smokers with arterial hypertension who switched to electronic cigarettes. Int J Environ Res Public Health. 2016; 13(11).
  41. Polosa R, Cibella F, Caponnetto P, et al. Health impact of e-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked. Sci Rep. 2017; 7(1): 13825.
  42. List of Classifications – IARC Monographs on the Identification of Carcinogenic Hazards to Humans. Available online: https://monographs.iarc.who.int/list-of-classifications. [Last accessed at 10.02.2021].
  43. Prevention (US) C for DC and, Promotion (US) NC for CDP and H, Health (US) O on S and. Figure 5.1, Link between cigarette smoking and cancer through carcinogens in tobacco smoke. Centers for Disease Control and Prevention (US); 2010. Available online: www.ncbi.nlm.nih.gov/books/NBK53010/figure/ch5.f1/. [Last accessed at 1.02.2021].
  44. National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems. Public Health Consequences of E-Cigarettes. Eaton DL, Kwan LY, Stratton K, editors. Washington (DC): National Academies Press (US); 2018. Available online: www.ncbi.nlm.nih.gov/books/NBK507171/. [Last accessed at: 10.02.2021].
  45. Mravec B, Tibensky M, Horvathova L, et al. E-Cigarettes and cancer risk. Cancer Prev Res (Phila). 2020; 13(2): 137–144.
  46. Pham K, Huynh Do, Le Le, et al. E-cigarette promotes breast carcinoma progression and lung metastasis: Macrophage-tumor cells crosstalk and the role of CCL5 and VCAM-1. Cancer Lett. 2020; 491: 132–145.
  47. Lee HW, Park SH, Weng MW, et al. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Natl Acad Sci U S A. 2018; 115(7): E1560–E1569.
  48. Visser WF, Klerx WN, Cremers HW, et al. The health risks of electronic cigarette use to bystanders. Int J Environ Res Public Health. 2019; 16(9).
  49. Czogala J, Goniewicz ML, Fidelus B, et al. Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob Res. 2014; 16(6): 655–662.
  50. Campus G, Cagetti MG, Senna A, et al. Does smoking increase risk for caries? A cross-sectional study in an Italian military academy. Caries Res. 2011; 45(1): 40–46.
  51. Coretti L, Cuomo M, Florio E, et al. Subgingival dysbiosis in smoker and non‑smoker patients with chronic periodontitis. Mol Med Rep. 2017; 15(4): 2007–2014.
  52. Sm M, Si A. Tobacco-associated lesions of the oral cavity: Part I. Nonmalignant lesions. Vol. 66, Journal (Canadian Dental Association). J Can Dent Assoc; 2000. Available onhttps://pubmed-1ncbi-1nlm-1nih-1gov-100001anf0279.han3.wum.edu.pl/10833868/. [Last accessed at: 10.02.2021].
  53. Irusa KF, Vence B, Donovan T. Potential oral health effects of e-cigarettes and vaping: A review and case reports. J Esthet Restor Dent. 2020; 32(3): 260–264.
  54. Vora MV, Chaffee BW. Tobacco-use patterns and self-reported oral health outcomes: A cross-sectional assessment of the Population Assessment of Tobacco and Health study, 2013-2014. J Am Dent Assoc. 2019; 150(5): 332–344.e2.
  55. Javed F, Abduljabbar T, Vohra F, et al. Comparison of periodontal parameters and self-perceived oral symptoms among cigarette smokers, individuals vaping electronic cigarettes, and never-smokers. J Periodontol. 2017; 88(10): 1059–1065.
  56. Tatullo M, Gentile S, Paduano F, et al. Crosstalk between oral and general health status in e-smokers. Medicine (Baltimore). 2016; 95(49): e5589.
  57. Polosa R, Morjaria JB, Caponnetto P, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med. 2014; 9(5): 537–546.
  58. Rouabhia M, Semlali A. Electronic cigarette vapor increases Streptococcus mutans growth, adhesion, biofilm formation, and expression of the biofilm-associated genes. Oral Dis. 2021; 27(3): 639–647.
  59. Smoking and infertility: a committee opinion. Fertil Steril. 2018 Sep 1. ; 110(4): 611–618.
  60. Wetendorf M, Randall LT, Lemma MT, et al. E-Cigarette exposure delays implantation and causes reduced weight gain in female offspring exposed . J Endocr Soc. 2019; 3(10): 1907–1916.
  61. El Golli N, Rahali D, Jrad-Lamine A, et al. Impact of electronic-cigarette refill liquid on rat testis. Toxicol Mech Methods. 2016; 26(6): 427–434.
  62. McCubbin A, Fallin-Bennett A, Barnett J, et al. Perceptions and use of electronic cigarettes in pregnancy. Health Educ Res. 2017; 32(1): 22–32.
  63. Chiang SC, Abroms LC, Cleary SD, et al. E-cigarettes and smoking cessation: a prospective study of a national sample of pregnant smokers. BMC Public Health. 2019; 19(1): 964.
  64. Wisborg K, Henriksen TB, Jespersen LB, et al. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol. 2000; 96(6): 967–971.
  65. Coleman T, Cooper S, Thornton JG, et al. A randomized trial of nicotine-replacement therapy patches in pregnancy. N Engl J Med. 2012; 366(9): 808–818.
  66. Orzabal MR, Lunde-Young ER, Ramirez JI, et al. Chronic exposure to e-cig aerosols during early development causes vascular dysfunction and offspring growth deficits. Transl Res. 2019; 207: 70–82.
  67. Liber AC, Drope JM, Stoklosa M. Combustible cigarettes cost less to use than e-cigarettes: global evidence and tax policy implications. Tob Control. 2017; 26(2): 158–163.
  68. Barrington-Trimis JL, Berhane K, Unger JB, et al. The e-cigarette social environment, e-cigarette use, and susceptibility to cigarette smoking. J Adolesc Health. 2016; 59(1): 75–80.
  69. McCabe SE, Veliz P, McCabe VV, et al. Smoking behaviors and intentions among current e-cigarette users, cigarette smokers, and dual users: A national survey of U.S. high school seniors. Prev Med. 2017; 99: 228–235.
  70. Selya AS, Dierker L, Rose JS, et al. The role of nicotine dependence in e-cigarettes' potential for smoking reduction. Nicotine Tob Res. 2018; 20(10): 1272–1277.
  71. Morean ME, Krishnan-Sarin S, O'Malley SS, et al. Comparing cigarette and e-cigarette dependence and predicting frequency of smoking and e-cigarette use in dual-users of cigarettes and e-cigarettes. Addict Behav. 2018; 87: 92–96.
  72. Liu G, Wasserman E, Kong L, et al. A comparison of nicotine dependence among exclusive E-cigarette and cigarette users in the PATH study. Prev Med. 2017; 104: 86–91.
  73. Hajek P, Phillips-Waller A, Przulj D, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019; 380(7): 629–637.
  74. Walker N, Parag V, Verbiest M, et al. Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial. Lancet Respir Med. 2020; 8(1): 54–64.
  75. Dawkins L, Munafò M, Christoforou G, et al. The effects of e-cigarette visual appearance on craving and withdrawal symptoms in abstinent smokers. Psychol Addict Behav. 2016; 30(1): 101–105.
  76. Lee A, Chakladar J, Li W, et al. Tobacco, but not nicotine and flavor-less electronic cigarettes, induces ACE2 and immune dysregulation. Int J Mol Sci. . 2020; 21(15): 5513.
  77. Reddy RK, Charles WN, Sklavounos A, et al. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. J Med Virol. 2021; 93(2): 1045–1056.
  78. Gaiha SM, Cheng J, Halpern-Felsher B. Association between youth smoking, electronic cigarette use, and COVID-19. J Adolesc Health. 2020; 67(4): 519–523.
  79. Münzel T, Hahad O, Kuntic M, et al. Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes. Eur Heart J. 2020; 41(41): 4057–4070.
  80. Soneji S, Barrington-Trimis JL, Wills TA, et al. Association between initial use of e-Cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr. 2017; 171(8): 788–797.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl